| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 204 / 466 | 56th | Q2 |
| Cardiology and Cardiovascular Medicine | 208 / 409 | 49th | Q3 |
| Radiology, Nuclear Medicine and Imaging | 185 / 361 | 48th | Q3 |
| Pulmonary and Respiratory Medicine | 88 / 165 | 46th | Q3 |
| Oncology | 264 / 428 | 38th | Q3 |
| Endocrinology, Diabetes and Metabolism | 165 / 250 | 34th | Q3 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Mediastinum
Mediastinum is Scopus-indexed (Q2, CiteScore 2.9), WoS ESCI. Published by AME Publishing Company.
Checked against the index lists dated .
ISSN 2522-6711Verify ISSN ↗
Publisher: AME Publishing Company
Cost to publish: No APC data — check the publisher
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Mediastinum indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q2, CiteScore 2.9.
What quartile is Mediastinum in Scopus?
Mediastinum is Q2 in Medicine (miscellaneous) (rank 204 of 466), Q3 in Cardiology and Cardiovascular Medicine (rank 208 of 409) and Q3 in Radiology, Nuclear Medicine and Imaging (rank 185 of 361), by CiteScore 2025. It is ranked in 6 subject areas in all.
What is the impact factor of Mediastinum?
Mediastinum is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.9, which places it in quartile Q2 at the 56th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.594, quartile Q2, with an H-index of 15.
Who publishes Mediastinum and what is its ISSN?
Mediastinum is published by AME Publishing Company. Its ISSN is 2522-6711.
Is Mediastinum in Web of Science?
Yes — indexed in the Emerging Sources Citation Index.
Is Mediastinum open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Mediastinum? — open metrics via OpenAlex
Mediastinum has an h-index of 21 and a 2-year mean of 1.15 citations per paper (OpenAlex). Its Scopus CiteScore is 2.9, quartile Q2. On 2-year citations it ranks #246 of 451 Scopus journals in Medicine (miscellaneous).
Mediastinum published 96 papers in 2025; its busiest recent year was 2024 with 116. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Who publishes in Mediastinum? — latest 89 articles, 2025–2026
In its latest 89 research articles (2025–2026), authors are most often from United States (25.3%), Japan (19.7%) and Italy (11.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Mediastinum? — indicators, not proof of misconduct
Scopus status: Active. 2 retracted papers are recorded (2.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers 2 · 2.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.